| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | negative regulation of NAD(P)H oxidase activity | 3.50e-05 | 3 | 71 | 2 | GO:0033861 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide catabolic process | 6.59e-05 | 63 | 71 | 4 | GO:0030811 | |
| GeneOntologyBiologicalProcess | regulation of purine nucleotide catabolic process | 6.59e-05 | 63 | 71 | 4 | GO:0033121 | |
| GeneOntologyBiologicalProcess | regulation of glycolytic process | 6.59e-05 | 63 | 71 | 4 | GO:0006110 | |
| GeneOntologyBiologicalProcess | negative regulation of glycogen catabolic process | 6.98e-05 | 4 | 71 | 2 | GO:0045818 | |
| GeneOntologyBiologicalProcess | positive regulation of nitric oxide mediated signal transduction | 6.98e-05 | 4 | 71 | 2 | GO:0010750 | |
| GeneOntologyBiologicalProcess | positive regulation of lipid kinase activity | 1.16e-04 | 5 | 71 | 2 | GO:0090218 | |
| GeneOntologyBiologicalProcess | negative regulation of respiratory burst involved in inflammatory response | 1.74e-04 | 6 | 71 | 2 | GO:0060266 | |
| GeneOntologyBiologicalProcess | regulation of NAD(P)H oxidase activity | 1.74e-04 | 6 | 71 | 2 | GO:0033860 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate catabolic process | 1.84e-04 | 82 | 71 | 4 | GO:0043470 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 1.98e-04 | 33 | 71 | 3 | GO:2000252 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 2.11e-04 | 85 | 71 | 4 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 2.11e-04 | 85 | 71 | 4 | GO:0000768 | |
| GeneOntologyBiologicalProcess | positive regulation of dendritic spine maintenance | 2.43e-04 | 7 | 71 | 2 | GO:1902952 | |
| GeneOntologyBiologicalProcess | syncytium formation | 2.52e-04 | 89 | 71 | 4 | GO:0006949 | |
| GeneOntologyBiologicalProcess | regulation of ATP metabolic process | 2.75e-04 | 91 | 71 | 4 | GO:1903578 | |
| GeneOntologyBiologicalProcess | negative regulation of respiratory burst | 3.23e-04 | 8 | 71 | 2 | GO:0060268 | |
| GeneOntologyBiologicalProcess | peptide hormone processing | 3.79e-04 | 41 | 71 | 3 | GO:0016486 | |
| GeneOntologyBiologicalProcess | respiratory burst | 4.37e-04 | 43 | 71 | 3 | GO:0045730 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 5.00e-04 | 45 | 71 | 3 | GO:0048521 | |
| GeneOntologyBiologicalProcess | positive regulation of respiratory burst | 5.16e-04 | 10 | 71 | 2 | GO:0060267 | |
| GeneOntologyBiologicalProcess | signaling receptor ligand precursor processing | 5.34e-04 | 46 | 71 | 3 | GO:0140448 | |
| GeneOntologyBiologicalProcess | glycolytic process | 5.65e-04 | 110 | 71 | 4 | GO:0006096 | |
| GeneOntologyBiologicalProcess | regulation of purine nucleotide metabolic process | 6.05e-04 | 112 | 71 | 4 | GO:1900542 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide metabolic process | 6.26e-04 | 113 | 71 | 4 | GO:0006140 | |
| GeneOntologyBiologicalProcess | regulation of lipid kinase activity | 6.30e-04 | 11 | 71 | 2 | GO:0043550 | |
| GeneOntologyBiologicalProcess | regulation of respiratory burst involved in inflammatory response | 6.30e-04 | 11 | 71 | 2 | GO:0060264 | |
| GeneOntologyBiologicalProcess | nitric oxide-cGMP-mediated signaling | 6.30e-04 | 11 | 71 | 2 | GO:0038060 | |
| GeneOntologyBiologicalProcess | ADP catabolic process | 6.47e-04 | 114 | 71 | 4 | GO:0046032 | |
| GeneOntologyBiologicalProcess | purine nucleoside diphosphate catabolic process | 7.13e-04 | 117 | 71 | 4 | GO:0009137 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside diphosphate catabolic process | 7.13e-04 | 117 | 71 | 4 | GO:0009181 | |
| GeneOntologyBiologicalProcess | insulin processing | 7.54e-04 | 12 | 71 | 2 | GO:0030070 | |
| GeneOntologyBiologicalProcess | pyridine nucleotide catabolic process | 7.60e-04 | 119 | 71 | 4 | GO:0019364 | |
| GeneOntologyBiologicalProcess | ADP metabolic process | 7.84e-04 | 120 | 71 | 4 | GO:0046031 | |
| GeneOntologyBiologicalProcess | ribonucleoside diphosphate catabolic process | 8.08e-04 | 121 | 71 | 4 | GO:0009191 | |
| GeneOntologyBiologicalProcess | pyridine-containing compound catabolic process | 8.60e-04 | 123 | 71 | 4 | GO:0072526 | |
| GeneOntologyBiologicalProcess | nucleoside diphosphate catabolic process | 8.86e-04 | 124 | 71 | 4 | GO:0009134 | |
| GeneOntologyBiologicalProcess | neuron projection maintenance | 8.89e-04 | 13 | 71 | 2 | GO:1990535 | |
| GeneOntologyBiologicalProcess | respiratory burst involved in inflammatory response | 8.89e-04 | 13 | 71 | 2 | GO:0002536 | |
| GeneOntologyBiologicalProcess | positive regulation of cytokine production | 8.93e-04 | 586 | 71 | 8 | GO:0001819 | |
| GeneOntologyBiologicalProcess | regulation of intrinsic apoptotic signaling pathway | 8.93e-04 | 216 | 71 | 5 | GO:2001242 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 9.12e-04 | 217 | 71 | 5 | GO:0051897 | |
| GeneOntologyBiologicalProcess | regulation of nitric oxide mediated signal transduction | 1.04e-03 | 14 | 71 | 2 | GO:0010749 | |
| GeneOntologyBiologicalProcess | regulation of glycogen catabolic process | 1.04e-03 | 14 | 71 | 2 | GO:0005981 | |
| GeneOntologyBiologicalProcess | myoblast fusion | 1.05e-03 | 58 | 71 | 3 | GO:0007520 | |
| GeneOntologyBiologicalProcess | regulation of apoptotic signaling pathway | 1.11e-03 | 467 | 71 | 7 | GO:2001233 | |
| GeneOntologyBiologicalProcess | alpha-beta T cell activation | 1.11e-03 | 227 | 71 | 5 | GO:0046631 | |
| GeneOntologyBiologicalProcess | purine nucleoside diphosphate metabolic process | 1.12e-03 | 132 | 71 | 4 | GO:0009135 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside diphosphate metabolic process | 1.12e-03 | 132 | 71 | 4 | GO:0009179 | |
| GeneOntologyBiologicalProcess | ER overload response | 1.19e-03 | 15 | 71 | 2 | GO:0006983 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate metabolic process | 1.20e-03 | 231 | 71 | 5 | GO:0006109 | |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 1.22e-03 | 61 | 71 | 3 | GO:0060259 | |
| GeneOntologyBiologicalProcess | negative regulation of glycogen metabolic process | 1.36e-03 | 16 | 71 | 2 | GO:0070874 | |
| GeneOntologyBiologicalProcess | positive regulation of glucose metabolic process | 1.40e-03 | 64 | 71 | 3 | GO:0010907 | |
| GeneOntologyBiologicalProcess | pyruvate metabolic process | 1.46e-03 | 142 | 71 | 4 | GO:0006090 | |
| GeneOntologyBiologicalProcess | ribonucleoside diphosphate metabolic process | 1.50e-03 | 143 | 71 | 4 | GO:0009185 | |
| GeneOntologyBiologicalProcess | intrinsic apoptotic signaling pathway | 1.52e-03 | 361 | 71 | 6 | GO:0097193 | |
| GeneOntologyBiologicalProcess | positive regulation of glycogen biosynthetic process | 1.72e-03 | 18 | 71 | 2 | GO:0045725 | |
| GeneOntologyBiologicalProcess | regulation of dendritic spine maintenance | 1.72e-03 | 18 | 71 | 2 | GO:1902950 | |
| GeneOntologyBiologicalProcess | negative regulation of acute inflammatory response | 1.72e-03 | 18 | 71 | 2 | GO:0002674 | |
| GeneOntologyBiologicalProcess | regulation of amino acid metabolic process | 1.72e-03 | 18 | 71 | 2 | GO:0006521 | |
| GeneOntologyBiologicalProcess | fatty acid homeostasis | 1.72e-03 | 18 | 71 | 2 | GO:0055089 | |
| GeneOntologyBiologicalProcess | nucleoside diphosphate metabolic process | 1.75e-03 | 149 | 71 | 4 | GO:0009132 | |
| GeneOntologyCellularComponent | extracellular matrix | ZP1 IGFALS SEMA7A ADAMTS4 MMP28 INS EFEMP2 NID1 CBLN1 INS-IGF2 FBN3 | 1.24e-05 | 656 | 71 | 11 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | ZP1 IGFALS SEMA7A ADAMTS4 MMP28 INS EFEMP2 NID1 CBLN1 INS-IGF2 FBN3 | 1.27e-05 | 658 | 71 | 11 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 7.45e-05 | 530 | 71 | 9 | GO:0062023 | |
| GeneOntologyCellularComponent | microfibril | 8.66e-04 | 13 | 71 | 2 | GO:0001527 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 9.23e-04 | 332 | 71 | 6 | GO:0005788 | |
| MousePheno | abnormal capillary morphology | 2.37e-05 | 93 | 52 | 5 | MP:0003658 | |
| Domain | cEGF | 2.01e-06 | 26 | 66 | 4 | IPR026823 | |
| Domain | cEGF | 2.01e-06 | 26 | 66 | 4 | PF12662 | |
| Domain | EGF_CA | 1.32e-05 | 86 | 66 | 5 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 2.37e-05 | 97 | 66 | 5 | IPR018097 | |
| Domain | EGF_CA | 2.61e-05 | 99 | 66 | 5 | PS01187 | |
| Domain | ASX_HYDROXYL | 2.74e-05 | 100 | 66 | 5 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.63e-05 | 106 | 66 | 5 | IPR000152 | |
| Domain | Peptidase_S28 | 3.68e-05 | 3 | 66 | 2 | IPR008758 | |
| Domain | Peptidase_S28 | 3.68e-05 | 3 | 66 | 2 | PF05577 | |
| Domain | EGF_CA | 7.12e-05 | 122 | 66 | 5 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 7.69e-05 | 124 | 66 | 5 | IPR001881 | |
| Domain | EGF_3 | 1.80e-04 | 235 | 66 | 6 | PS50026 | |
| Domain | EGF | 1.80e-04 | 235 | 66 | 6 | SM00181 | |
| Domain | Growth_fac_rcpt_ | 2.26e-04 | 156 | 66 | 5 | IPR009030 | |
| Domain | EGF-like_dom | 2.46e-04 | 249 | 66 | 6 | IPR000742 | |
| Domain | EGF_1 | 2.80e-04 | 255 | 66 | 6 | PS00022 | |
| Domain | EGF-like_CS | 3.17e-04 | 261 | 66 | 6 | IPR013032 | |
| Domain | EGF_2 | 3.43e-04 | 265 | 66 | 6 | PS01186 | |
| Domain | - | 4.36e-04 | 9 | 66 | 2 | 1.10.100.10 | |
| Domain | Insulin | 5.43e-04 | 10 | 66 | 2 | PF00049 | |
| Domain | Insulin | 6.63e-04 | 11 | 66 | 2 | IPR004825 | |
| Domain | - | 6.63e-04 | 11 | 66 | 2 | 2.40.155.10 | |
| Domain | GFP-like | 6.63e-04 | 11 | 66 | 2 | IPR023413 | |
| Domain | Insulin-like | 6.63e-04 | 11 | 66 | 2 | IPR016179 | |
| Domain | IlGF | 6.63e-04 | 11 | 66 | 2 | SM00078 | |
| Domain | EGF_3 | 7.93e-04 | 12 | 66 | 2 | PF12947 | |
| Domain | EGF_dom | 7.93e-04 | 12 | 66 | 2 | IPR024731 | |
| Domain | MetalloPept_cat_dom | 2.95e-03 | 81 | 66 | 3 | IPR024079 | |
| Domain | - | 2.95e-03 | 81 | 66 | 3 | 3.40.390.10 | |
| Domain | ACR | 4.08e-03 | 27 | 66 | 2 | SM00608 | |
| Domain | ADAM_Cys-rich | 4.08e-03 | 27 | 66 | 2 | IPR006586 | |
| Domain | ZINC_PROTEASE | 5.05e-03 | 98 | 66 | 3 | PS00142 | |
| Domain | JMJC | 5.70e-03 | 32 | 66 | 2 | PS51184 | |
| Domain | JmjC_dom | 5.70e-03 | 32 | 66 | 2 | IPR003347 | |
| Domain | JmjC | 6.05e-03 | 33 | 66 | 2 | SM00558 | |
| Domain | Cadherin_CS | 6.78e-03 | 109 | 66 | 3 | IPR020894 | |
| Domain | CADHERIN_1 | 7.48e-03 | 113 | 66 | 3 | PS00232 | |
| Domain | Cadherin | 7.48e-03 | 113 | 66 | 3 | PF00028 | |
| Domain | Cadherin_tail | 7.56e-03 | 37 | 66 | 2 | PF15974 | |
| Domain | Cadherin_CBD | 7.56e-03 | 37 | 66 | 2 | IPR031904 | |
| Domain | CADHERIN_2 | 7.67e-03 | 114 | 66 | 3 | PS50268 | |
| Domain | - | 7.67e-03 | 114 | 66 | 3 | 2.60.40.60 | |
| Domain | CA | 7.85e-03 | 115 | 66 | 3 | SM00112 | |
| Domain | Cadherin-like | 8.04e-03 | 116 | 66 | 3 | IPR015919 | |
| Domain | Peptidase_M12B_N | 8.38e-03 | 39 | 66 | 2 | IPR002870 | |
| Domain | Pep_M12B_propep | 8.38e-03 | 39 | 66 | 2 | PF01562 | |
| Domain | Cadherin | 8.43e-03 | 118 | 66 | 3 | IPR002126 | |
| Domain | DISINTEGRIN_1 | 8.80e-03 | 40 | 66 | 2 | PS00427 | |
| Domain | LDLR_class-A_CS | 8.80e-03 | 40 | 66 | 2 | IPR023415 | |
| Domain | Reprolysin | 8.80e-03 | 40 | 66 | 2 | PF01421 | |
| Domain | ADAM_MEPRO | 8.80e-03 | 40 | 66 | 2 | PS50215 | |
| Domain | DISINTEGRIN_2 | 8.80e-03 | 40 | 66 | 2 | PS50214 | |
| Domain | Peptidase_M12B | 8.80e-03 | 40 | 66 | 2 | IPR001590 | |
| Domain | Disintegrin_dom | 9.23e-03 | 41 | 66 | 2 | IPR001762 | |
| Domain | EGF | 1.01e-02 | 126 | 66 | 3 | PF00008 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | SIAE LRP12 GINM1 PTPRJ TNFSF9 RPN2 ADAM9 JMJD8 LRP11 TM9SF3 CD55 ULBP2 NID1 TMEM43 DNAJC1 BACE2 MTCH2 ALG1 | 2.37e-11 | 1201 | 71 | 18 | 35696571 |
| Pubmed | LRRC25 GINM1 ADAMTS4 SUSD1 MMP28 UNC5B RNASE7 EFEMP2 TM9SF3 PSCA IL20RA ULBP2 TMEM43 BACE2 ALG1 | 1.13e-09 | 985 | 71 | 15 | 12975309 | |
| Pubmed | 1.33e-06 | 11 | 71 | 3 | 6795447 | ||
| Pubmed | Multiple related immunoglobulin variable-region genes identified by cloning and sequence analysis. | 1.33e-06 | 11 | 71 | 3 | 279004 | |
| Pubmed | 1.33e-06 | 11 | 71 | 3 | 15739225 | ||
| Pubmed | Organization and complete sequence of identical embryonic and plasmacytoma kappa V-region genes. | 1.33e-06 | 11 | 71 | 3 | 6767723 | |
| Pubmed | Mart1 is located on mouse chromosome 19 and is excluded as a candidate for ep and ru. | 1.77e-06 | 12 | 71 | 3 | 9107690 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 9593767 | ||
| Pubmed | SGLT1/2 inhibition improves glycemic control and multi-organ protection in type 1 diabetes. | 4.11e-06 | 2 | 71 | 2 | 37520739 | |
| Pubmed | Neuritic dystrophy and neuronopathy in Akita (Ins2(Akita)) diabetic mouse sympathetic ganglia. | 4.11e-06 | 2 | 71 | 2 | 19111542 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 35830687 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 26733677 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 37628852 | ||
| Pubmed | Proinsulin I and II gene expression in inbred mouse strains. | 4.11e-06 | 2 | 71 | 2 | 2608062 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 27335233 | ||
| Pubmed | Expression of preproinsulin-2 gene shapes the immune response to preproinsulin in normal mice. | 4.11e-06 | 2 | 71 | 2 | 14688305 | |
| Pubmed | Bioinformatics Analysis of Weighted Genes in Diabetic Retinopathy. | 4.11e-06 | 2 | 71 | 2 | 30480744 | |
| Pubmed | The implications of hyperoxia, type 1 diabetes and sex on cardiovascular physiology in mice. | 4.11e-06 | 2 | 71 | 2 | 34845324 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 24226524 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 7031649 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 16289958 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 22522616 | ||
| Pubmed | Identification of novel targets of diabetic nephropathy and PEDF peptide treatment using RNA-seq. | 4.11e-06 | 2 | 71 | 2 | 27855634 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 1346376 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 26203118 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 23552863 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 27782077 | ||
| Pubmed | Specific dynamic and noninvasive labeling of pancreatic beta cells in reporter mice. | 4.11e-06 | 2 | 71 | 2 | 16283623 | |
| Pubmed | Type 1 diabetic Akita mice have low bone mass and impaired fracture healing. | 4.11e-06 | 2 | 71 | 2 | 33662611 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 29995913 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 15718275 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 29029025 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 20948967 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 20520806 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 16799061 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 37279936 | ||
| Pubmed | An imprinted GFP insertion reveals long-range epigenetic regulation in embryonic lineages. | 4.11e-06 | 2 | 71 | 2 | 19778534 | |
| Pubmed | Insulin Knockout Mice Have Extended Survival but Volatile Blood Glucose Levels on Leptin Therapy. | 4.11e-06 | 2 | 71 | 2 | 26696124 | |
| Pubmed | In Vivo Capillary Structure and Blood Cell Flux in the Normal and Diabetic Mouse Eye. | 4.11e-06 | 2 | 71 | 2 | 35138346 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 25686499 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 23209676 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 27055260 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 12059784 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 19801494 | ||
| Pubmed | Increasing hepatic glycogen moderates the diabetic phenotype in insulin-deficient Akita mice. | 4.11e-06 | 2 | 71 | 2 | 33667544 | |
| Pubmed | Tissue- and developmental stage-specific imprinting of the mouse proinsulin gene, Ins2. | 4.11e-06 | 2 | 71 | 2 | 7729600 | |
| Pubmed | Genetic modulation of diabetic nephropathy among mouse strains with Ins2 Akita mutation. | 4.11e-06 | 2 | 71 | 2 | 25428948 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 26595448 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 22015457 | ||
| Pubmed | Altered Gut Microbiota Activate and Expand Insulin B15-23-Reactive CD8+ T Cells. | 4.11e-06 | 2 | 71 | 2 | 30796028 | |
| Pubmed | Impact of genetic background on nephropathy in diabetic mice. | 4.11e-06 | 2 | 71 | 2 | 16118394 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 23391566 | ||
| Pubmed | Reduced Circulating Insulin Enhances Insulin Sensitivity in Old Mice and Extends Lifespan. | 4.11e-06 | 2 | 71 | 2 | 28700945 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 23275337 | ||
| Pubmed | Novel diabetic mouse models as tools for investigating diabetic retinopathy. | 4.11e-06 | 2 | 71 | 2 | 23251343 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 25789863 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 17151334 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 21593201 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 36170671 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 21723250 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 34675883 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 15005713 | ||
| Pubmed | Does rosiglitazone affect adiposity and cardiac function in genetic diabetic mice? | 4.11e-06 | 2 | 71 | 2 | 23228931 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 23894189 | ||
| Pubmed | Metabolic effects of short-term caloric restriction in mice with reduced insulin gene dosage. | 4.11e-06 | 2 | 71 | 2 | 29439088 | |
| Pubmed | Hyperglycemia and xerostomia are key determinants of tooth decay in type 1 diabetic mice. | 4.11e-06 | 2 | 71 | 2 | 22449801 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 19874548 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 29434227 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 35234250 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 16936198 | ||
| Pubmed | Tissue-specific remodeling of the mitochondrial proteome in type 1 diabetic akita mice. | 4.11e-06 | 2 | 71 | 2 | 19542201 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 30019207 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 27620487 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 31040360 | ||
| Pubmed | Imprinting at the mouse Ins2 locus: evidence for cis- and trans-allelic interactions. | 4.11e-06 | 2 | 71 | 2 | 9465295 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 15972000 | ||
| Pubmed | Circulating sphingolipid biomarkers in models of type 1 diabetes. | 4.11e-06 | 2 | 71 | 2 | 21068007 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 28837672 | ||
| Pubmed | Inducing Specific Immune Tolerance to Prevent Type 1 Diabetes in NOD Mice. | 4.11e-06 | 2 | 71 | 2 | 26784909 | |
| Pubmed | Novel splice variant of mouse insulin2 mRNA: implications for insulin expression. | 4.11e-06 | 2 | 71 | 2 | 20153322 | |
| Pubmed | Noninvasive temporal detection of early retinal vascular changes during diabetes. | 4.11e-06 | 2 | 71 | 2 | 33060607 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 31069235 | ||
| Pubmed | High fat diet induces brain insulin resistance and cognitive impairment in mice. | 4.11e-06 | 2 | 71 | 2 | 27771511 | |
| Pubmed | Activation of endothelial NAD(P)H oxidase accelerates early glomerular injury in diabetic mice. | 4.11e-06 | 2 | 71 | 2 | 26552047 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 22915034 | ||
| Pubmed | Predisposition to Proinsulin Misfolding as a Genetic Risk to Diet-Induced Diabetes. | 4.11e-06 | 2 | 71 | 2 | 34462258 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 20825366 | ||
| Pubmed | Misfolded proinsulin affects bystander proinsulin in neonatal diabetes. | 4.11e-06 | 2 | 71 | 2 | 19880509 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 22065673 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 18788099 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 17459508 | ||
| Pubmed | Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. | 4.11e-06 | 2 | 71 | 2 | 15889095 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 7911222 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 28883608 | ||
| Pubmed | Dominant negative pathogenesis by mutant proinsulin in the Akita diabetic mouse. | 4.11e-06 | 2 | 71 | 2 | 12540615 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 12914928 | ||
| Pubmed | Complications of IgA nephropathy in a non-insulin-dependent diabetes model, the Akita mouse. | 4.11e-06 | 2 | 71 | 2 | 12630555 | |
| Pubmed | Retinal blood flow abnormalities following six months of hyperglycemia in the Ins2(Akita) mouse. | 4.11e-06 | 2 | 71 | 2 | 22440813 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 36265286 | ||
| Pubmed | Dominant protein interactions that influence the pathogenesis of conformational diseases. | 4.11e-06 | 2 | 71 | 2 | 23722904 | |
| Interaction | TCTN2 interactions | 9.21e-07 | 304 | 69 | 9 | int:TCTN2 | |
| Interaction | BRICD5 interactions | 4.48e-06 | 194 | 69 | 7 | int:BRICD5 | |
| Interaction | DIPK1A interactions | 1.50e-05 | 91 | 69 | 5 | int:DIPK1A | |
| Interaction | HLA-C interactions | 2.70e-05 | 353 | 69 | 8 | int:HLA-C | |
| Interaction | TMEM59 interactions | 3.62e-05 | 181 | 69 | 6 | int:TMEM59 | |
| Interaction | ADAMTS2 interactions | 4.04e-05 | 56 | 69 | 4 | int:ADAMTS2 | |
| Interaction | WNT5A interactions | 9.20e-05 | 69 | 69 | 4 | int:WNT5A | |
| Interaction | RNF149 interactions | 1.02e-04 | 549 | 69 | 9 | int:RNF149 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q25 | 1.27e-04 | 164 | 71 | 4 | chr6q25 | |
| Cytoband | 6q25 | 1.54e-04 | 12 | 71 | 2 | 6q25 | |
| Cytoband | 2p12 | 8.13e-04 | 117 | 71 | 3 | 2p12 | |
| Cytoband | 6q25.1 | 1.60e-03 | 38 | 71 | 2 | 6q25.1 | |
| GeneFamily | Low density lipoprotein receptors | 6.20e-04 | 13 | 52 | 2 | 634 | |
| GeneFamily | Solute carriers | 9.12e-04 | 395 | 52 | 6 | 752 | |
| GeneFamily | Immunoglobulin kappa locus at 2p11.2 | 1.75e-03 | 83 | 52 | 3 | 351 | |
| GeneFamily | Glycosyltransferase family 6|Blood group antigens | 5.07e-03 | 37 | 52 | 2 | 454 | |
| Coexpression | NABA_MATRISOME | ZP1 SERPINA11 FNDC1 FLT3LG IGFALS SCUBE2 SEMA7A ADAMTS4 TNFSF9 MMP28 INS ADAM9 WNT16 EFEMP2 NID1 CBLN1 INS-IGF2 FBN3 | 1.76e-10 | 1026 | 71 | 18 | M5889 |
| Coexpression | NABA_MATRISOME | ZP1 SERPINA11 FNDC1 FLT3LG IGFALS SCUBE2 SEMA7A ADAMTS4 TNFSF9 MMP28 INS ADAM9 WNT16 EFEMP2 NID1 CBLN1 INS-IGF2 | 1.13e-09 | 1008 | 71 | 17 | MM17056 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | SERPINA11 FLT3LG SCUBE2 SEMA7A ADAMTS4 TNFSF9 MMP28 INS ADAM9 WNT16 CBLN1 INS-IGF2 | 6.35e-07 | 738 | 71 | 12 | MM17058 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | SERPINA11 FLT3LG SCUBE2 SEMA7A ADAMTS4 TNFSF9 MMP28 INS ADAM9 WNT16 CBLN1 INS-IGF2 | 7.63e-07 | 751 | 71 | 12 | M5885 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.55e-05 | 196 | 71 | 6 | M3008 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | 3.27e-05 | 457 | 71 | 8 | M1613 | |
| Coexpression | NABA_SECRETED_FACTORS | 3.65e-05 | 338 | 71 | 7 | MM17064 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | 3.99e-05 | 470 | 71 | 8 | MM1053 | |
| Coexpression | NABA_SECRETED_FACTORS | 4.01e-05 | 343 | 71 | 7 | M5883 | |
| Coexpression | NABA_MATRISOME_METASTATIC_COLORECTAL_LIVER_METASTASIS | 7.34e-05 | 30 | 71 | 3 | M47990 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | LRP12 TNFSF9 TM9SF3 TMEM115 NID1 TMEM43 DNAJC1 PTTG1IP MFSD10 | 9.06e-05 | 681 | 71 | 9 | M5314 |
| Coexpression | AKT_UP.V1_UP | 9.70e-05 | 169 | 71 | 5 | M2669 | |
| Coexpression | NABA_CORE_MATRISOME | 1.02e-04 | 275 | 71 | 6 | M5884 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | LRP12 TNFSF9 TM9SF3 TMEM115 NID1 TMEM43 DNAJC1 PTTG1IP MFSD10 | 1.15e-04 | 703 | 71 | 9 | MM1055 |
| Coexpression | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3 | 1.47e-04 | 726 | 71 | 9 | M4210 | |
| Coexpression | WANG_SMARCE1_TARGETS_UP | 1.47e-04 | 294 | 71 | 6 | M1804 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C1_DCLK1POS_PROGENITOR | 1.53e-04 | 99 | 71 | 4 | M39152 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.72e-04 | 191 | 71 | 5 | MM17059 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | FZD1 CNNM1 FNDC1 GPR150 TNFSF9 GPR62 UNC5B WNT16 SIDT1 ULBP2 CBLN1 | 1.93e-04 | 1115 | 71 | 11 | M10371 |
| Coexpression | GSE43863_NAIVE_VS_MEMORY_LY6C_INT_CXCR5POS_CD4_TCELL_D150_LCMV_UP | 2.13e-04 | 200 | 71 | 5 | M9739 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.53e-08 | 193 | 71 | 7 | a5695ce2e24a62026ae28f3dea07ca4a435206b8 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.38e-07 | 197 | 71 | 6 | 88b29d205237f07a9a26cc15a1cf4ed4816a4c4b | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_cell-B_naive|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.60e-07 | 198 | 71 | 6 | 79c690d21d3420d0bb1a3b3b4ea2c9aa3810a219 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.68e-06 | 165 | 71 | 5 | 22293c6b55f44636440cd737efb786ff5de3373d | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-B-CD5+_CCL22+_mature_B|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.89e-06 | 175 | 71 | 5 | fa53ea81ad943a2cd266114829135cbcbcf2f634 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 9.66e-06 | 178 | 71 | 5 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-pDC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.05e-05 | 181 | 71 | 5 | 60607c5ff6d5b1cb416adc034491dca31c41e988 | |
| ToppCell | Globus_pallidus-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Ttyh1_(Ttyh1)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.10e-05 | 86 | 71 | 4 | c7d17025bad7bb57f034064ff2c9d9919509ef9a | |
| ToppCell | Globus_pallidus-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Ttyh1_(Ttyh1)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.10e-05 | 86 | 71 | 4 | 95fea8fc55c9f321ef9285f05dc144a5f817f2da | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 183 | 71 | 5 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | Mild-Lymphoid-B|Mild / Condition, Lineage, Cell class and cell subclass | 1.10e-05 | 183 | 71 | 5 | 9b64d2d143525e6f48a191facfd101462ff36324 | |
| ToppCell | Mild_COVID-19-B_cell|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.10e-05 | 183 | 71 | 5 | dea119e2988e954475f557f0bbe12556a83e81a4 | |
| ToppCell | Mild-Lymphoid-B-|Mild / Condition, Lineage, Cell class and cell subclass | 1.10e-05 | 183 | 71 | 5 | b5740f05a4dcdbbf24f7bf7a3f57ac01a5e75f60 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.10e-05 | 183 | 71 | 5 | 01664fce6b70a02c9d39d747b6a6aabc86d57bc2 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-B_cells-Immature_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-05 | 186 | 71 | 5 | 459a7e97bbac2b2cd253aa4ab38d0e4ae6191e8b | |
| ToppCell | Mild_COVID-19-B_cell-B_cell|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.19e-05 | 186 | 71 | 5 | 855a5a00ba2aa1b5c63b8db56d026ddecc546050 | |
| ToppCell | 15-Trachea-Epithelial-Secretory_progenitor|Trachea / Age, Tissue, Lineage and Cell class | 1.23e-05 | 187 | 71 | 5 | be9fce9e74b2f170a2067f1b31d802912a578329 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.26e-05 | 188 | 71 | 5 | aa516273cdde53c8c0295f06830972388f890c97 | |
| ToppCell | 10x5'-Liver-Lymphocytic_B|Liver / Manually curated celltypes from each tissue | 1.29e-05 | 189 | 71 | 5 | 1ebff8185060d78f27f8d887e9adaa5f8faf2196 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.29e-05 | 189 | 71 | 5 | 5a42be62552d912d0abf68f00d75ac80bbd69f2c | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-B-CD5-_Mature_B|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.32e-05 | 190 | 71 | 5 | ade43d1d1f8909b8526a23152acf3c26f160f836 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-plasma_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.32e-05 | 190 | 71 | 5 | 76b747bafff09bf8375a5717c9f213cbfb405bac | |
| ToppCell | COVID-19_Severe-Lymphoid_B-B_intermediate|COVID-19_Severe / Disease group, lineage and cell class | 1.43e-05 | 193 | 71 | 5 | ea079e6f7242a2bbc8260299ad9e9bdabb9856f8 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC3-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.43e-05 | 193 | 71 | 5 | 30abf991ac17c18679ab7d633e7549c0ce841920 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.43e-05 | 193 | 71 | 5 | b5e44fe60dc84dc050d4fa3ccec4e257e51dc636 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.43e-05 | 193 | 71 | 5 | e2cf2f4f142e1b4dda3ded28b5208eef3f301a43 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.46e-05 | 194 | 71 | 5 | 7f62bd52779e2779447b23bdd330be4b5b35910a | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-05 | 194 | 71 | 5 | ee6b5fb4e993a4c0dc556091b8fefd56bdc70d8f | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-05 | 195 | 71 | 5 | 841fde528ecb293e07b5e00e499d1e9f0b0dce14 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-05 | 195 | 71 | 5 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | Goblet_1|World / shred by cell class for nasal brushing | 1.50e-05 | 195 | 71 | 5 | d9e4889a2e7b7c97c07c15b043b77837739462e4 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.58e-05 | 197 | 71 | 5 | 9fe1b757f76c2d43d39aa9ac500eaba98723985c | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-B-B_intermediate|COVID-19_Severe / Disease, condition lineage and cell class | 1.65e-05 | 199 | 71 | 5 | ad3c369a67926725917b771094f82ca6dd2af783 | |
| ToppCell | PND07-28-samps-Lymphocyte-T_cells-T_cells_2|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 7.02e-05 | 138 | 71 | 4 | 221a964e86d7d3406cdb7573899155fee8d33abd | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 155 | 71 | 4 | 8fdda4e3657ac56188ae88ed3caf145f4d9d1567 | |
| ToppCell | 343B-Myeloid-Dendritic-pDC|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.13e-04 | 156 | 71 | 4 | 547e2debfc09c07c049a880dded5fda7dd53e156 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-04 | 156 | 71 | 4 | 33deda19f06172079ef1dd49fd54d66da1e7fb14 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-5|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.16e-04 | 157 | 71 | 4 | 5fb41af247465aa29aa7b8edd26e3d3794766f80 | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 158 | 71 | 4 | 8844fba9c1e41f062edf3110d025f33b86afb951 | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 158 | 71 | 4 | c56607cba9a3719ac6d573d970686053e1676985 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Cbln1-Excitatory_Neuron.Slc17a7.Reln_(Medial_entorrhinal_cortexm,_Reln+/Cbln1+)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.27e-04 | 61 | 71 | 3 | 5e855b5462f42b7a1d0bbd518cc11072342ce0cc | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Cbln1-Excitatory_Neuron.Slc17a7.Reln_(Medial_entorrhinal_cortexm,_Reln+/Cbln1+)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.27e-04 | 61 | 71 | 3 | 2fc13475581431f82e0b5ef42e18cd29c9787666 | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 161 | 71 | 4 | 441ebd3c029861d833fbcf8a68fc740d9de8ef2f | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.30e-04 | 162 | 71 | 4 | b46158e260bd2f35702cec73e3b035e8e9ec4469 | |
| ToppCell | facs-Heart-LV-24m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 163 | 71 | 4 | 648d5439811b64412bc4678646f216105b90b9a1 | |
| ToppCell | facs-Trachea-18m-Hematologic-lymphocytic-B_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.37e-04 | 164 | 71 | 4 | 4274a4f225cabf61f0fe27d8ea162b4eba612f87 | |
| ToppCell | facs-Trachea-18m-Hematologic-lymphocytic-B_cell-B_cell_of_the_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.37e-04 | 164 | 71 | 4 | d62143450f59097ad4b34603a6257f897a769ead | |
| ToppCell | droplet-Fat-SCAT-30m-Lymphocytic-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 166 | 71 | 4 | 67370c49d7aedcb4eca802095f06b30f6bbf8919 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 166 | 71 | 4 | 3e3e9296e6919a38602e417a6606c046af3bd101 | |
| ToppCell | droplet-Fat-SCAT-30m-Lymphocytic|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 166 | 71 | 4 | 7f4e5976ede6478636aa567d6fc2b56ff7295fb8 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Pde1a_(dSPN)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.46e-04 | 64 | 71 | 3 | def8cf047ec3ba3c40bb759d0910838df857f05b | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Pde1a_(dSPN)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.46e-04 | 64 | 71 | 3 | cec968dc404934fa9888d445d7c4cd2df7f3cc7a | |
| ToppCell | 367C-Myeloid-Dendritic-pDC|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.47e-04 | 167 | 71 | 4 | 650de8cd5df070639b8aa292aacead739cfdb02c | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.47e-04 | 167 | 71 | 4 | 3c3e1c31aacca48099693aea2efdfa22fc0e4af4 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-Zbtb32+_B_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.47e-04 | 167 | 71 | 4 | 77a4d7ce44847c76074d4f5340d61b398fe43e6c | |
| ToppCell | 10x5'-GI_large-bowel|World / Manually curated celltypes from each tissue | 1.50e-04 | 168 | 71 | 4 | 1290c909655bc37f6b8bf216d18127a21b99e9c0 | |
| ToppCell | BAL-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.53e-04 | 169 | 71 | 4 | 307571e57c3bfdf15f0fe1a8b36585e8e4f8a207 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.53e-04 | 169 | 71 | 4 | db73dae011ff3749b3706e50ab46d03b775dd6bb | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.53e-04 | 169 | 71 | 4 | 97b7047b87ce0052d8580565c9b44fd2aa6f0d5c | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.53e-04 | 169 | 71 | 4 | 1a684471dbda42e1470e5a889648666e14f25982 | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell-B_activate-7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.57e-04 | 170 | 71 | 4 | ee2ee67d90ae4596de8ccd620e37c82cf51651d4 | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.57e-04 | 170 | 71 | 4 | d7ca0c6ce5d2b7de99346f87e07aa7fe728fa08a | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.57e-04 | 170 | 71 | 4 | 92e765ae0d3adb38d3b22fddb873fd5ccad3fd44 | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.57e-04 | 170 | 71 | 4 | 52787f6d529c285d9f0c04cc022710ead5b89b3f | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.57e-04 | 170 | 71 | 4 | 9f8b215caa1afa3cd7104c06fca7cfd790640f66 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-04 | 171 | 71 | 4 | 59b9dbaa05b6e5740edc633c9ce1181565550d5b | |
| ToppCell | Myeloid-Myeloid-D_(Mast_cell)|Myeloid / shred on cell class and cell subclass (v4) | 1.60e-04 | 171 | 71 | 4 | 5f1aafc4c55a9c6c3153430186a8a351425a3cb9 | |
| ToppCell | mild-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.60e-04 | 171 | 71 | 4 | 5c8198182495bda7a826e9d80aa467f4eb1094ec | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-04 | 171 | 71 | 4 | a5b9dd2b6a54db7962beeb5a9ceb9dacfb613fa7 | |
| ToppCell | wk_08-11-Hematologic_Lymphocytic-B|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.64e-04 | 172 | 71 | 4 | d1ab8f493b70ec995281f9fb0991f1d3aa7b928f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.72e-04 | 174 | 71 | 4 | 5f4436863a40f8bca46e2989bca66c02b6be88d4 | |
| ToppCell | TCGA-Colorectal-Recurrent_Tumor|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.75e-04 | 175 | 71 | 4 | 7f74961436f88c0e380819095e6104489914d765 | |
| ToppCell | TCGA-Colorectal-Recurrent_Tumor-Colorectal_Adenocarcinoma|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.75e-04 | 175 | 71 | 4 | bee8f31f036dfcf9fc6ed29156554771a9ee3c60 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-NK_T_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.79e-04 | 176 | 71 | 4 | 1ea45cf7b7e12206c3eca1594173368643c50e59 | |
| ToppCell | droplet-Fat-SCAT-30m-Lymphocytic-T_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 177 | 71 | 4 | baf78a8dad55f124f56585f88b10b58c0269680f | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Zbtb32+_B_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.83e-04 | 177 | 71 | 4 | a58c93be9767e3fe8fbb6b0db1210d3a33aac662 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.83e-04 | 177 | 71 | 4 | 3ed383e5c0b15d9d5e75b98cf6d10609f48fc422 | |
| ToppCell | (06)_Krt4/13+|World / shred by cell type and Timepoint | 1.87e-04 | 178 | 71 | 4 | 46efdf03aa1317bc600138e871509b995e773cce | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.87e-04 | 178 | 71 | 4 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.87e-04 | 178 | 71 | 4 | 107dae8b00c4257697a63700e72bb434cdb8406f | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-04 | 178 | 71 | 4 | 9b932b677ae05ac6e12cd6ce97789f8c10e4790b | |
| ToppCell | facs-Kidney-nan-18m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-04 | 179 | 71 | 4 | f4fd214a9865c635d8a744ce5e0eff45174d3de4 | |
| ToppCell | facs-Kidney-nan-18m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-04 | 179 | 71 | 4 | 57d8d44a793314eec8f77030f4177bfe21d41652 | |
| ToppCell | moderate-Myeloid-pDC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.95e-04 | 180 | 71 | 4 | 1d8df7df03a71f49d6683554d3c948ce90dda42e | |
| ToppCell | facs-Bladder-nan-24m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 180 | 71 | 4 | 12537d8a569faa69f474284d2c201475722b8ca1 | |
| ToppCell | BAL-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.99e-04 | 181 | 71 | 4 | 700adfb41e4e377530f0dd31be89e12f109f3469 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-lymphocytic-B_lymphocytic-memory_B_cell|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.99e-04 | 181 | 71 | 4 | 768d14c452192f92fa557ae59e84c43436f575f0 | |
| ToppCell | 10x5'-Liver-Lymphocytic_B-Memory_B_cells|Liver / Manually curated celltypes from each tissue | 1.99e-04 | 181 | 71 | 4 | a9f4df288c34e3b2b6ed861ac6cda970c3ee08b1 | |
| ToppCell | tumor_Lung-Myeloid_cells-pDCs|tumor_Lung / Location, Cell class and cell subclass | 1.99e-04 | 181 | 71 | 4 | c864ffeb9234b8c29754afc91c85a972889617f4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-04 | 182 | 71 | 4 | 678eadd57e7e830fc2bf9fd35616d3badce01705 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-04 | 182 | 71 | 4 | 8d1229fa5aa6e2e38f2ac6fe4f4dc89752fe9344 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.04e-04 | 182 | 71 | 4 | 94e70746e35a3062015d4b83ee545f4f84f47420 | |
| ToppCell | Severe_COVID-19-B_cell-B_cell|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.08e-04 | 183 | 71 | 4 | 5634e528001c389efd1e380f01ad40072f60e943 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.08e-04 | 183 | 71 | 4 | cf5c98f451a568308c52da5c926543dd4836c6b2 | |
| ToppCell | B_cell_maturation-plasma|World / Lineage and Cell class | 2.08e-04 | 183 | 71 | 4 | 0c3cb61912df05f1beba1004540770ef1a4de786 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-B-CD5+_CCL22-_mature_B|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.12e-04 | 184 | 71 | 4 | 18aa9c43b79d12c9e420dfd9822745c022be6789 | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.12e-04 | 184 | 71 | 4 | 3f8a359e40bebe58545f708682e5e5d1b70cf5cb | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.12e-04 | 184 | 71 | 4 | 64bede8db709fd32f40c03265b96f0b12155bb8a | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-Mast_cells|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.17e-04 | 185 | 71 | 4 | a6e5328801c233a44153420e2cdae644b253f540 | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.17e-04 | 185 | 71 | 4 | 609080adb2cfb105bb7b8efb617553833299f371 | |
| Disease | 5-methylthioadenosine (MTA) measurement | 2.03e-07 | 6 | 65 | 3 | EFO_0800130 | |
| Disease | X-25420 measurement | 1.43e-05 | 3 | 65 | 2 | EFO_0800926 | |
| Disease | beta-aminoisobutyric acid measurement | 2.00e-05 | 24 | 65 | 3 | EFO_0010464 | |
| Disease | 1-ribosyl-imidazoleacetate measurement | 1.70e-04 | 9 | 65 | 2 | EFO_0800034 | |
| Disease | latent autoimmune diabetes in adults, type 2 diabetes mellitus | 1.70e-04 | 9 | 65 | 2 | EFO_0009706, MONDO_0005148 | |
| Disease | Alzheimer's disease (biomarker_via_orthology) | 2.89e-04 | 58 | 65 | 3 | DOID:10652 (biomarker_via_orthology) | |
| Disease | serum urea measurement | 9.14e-04 | 195 | 65 | 4 | EFO_0009795 | |
| Disease | macular telangiectasia type 2 | 1.50e-03 | 26 | 65 | 2 | EFO_1002009 | |
| Disease | neutrophil count, basophil count | 1.52e-03 | 224 | 65 | 4 | EFO_0004833, EFO_0005090 | |
| Disease | 1,5 anhydroglucitol measurement | 1.87e-03 | 29 | 65 | 2 | EFO_0008009 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RALLLPLLAQWLLRA | 6 | Q9Y5Z0 | |
| LCLLLPLLLLGGWKR | 11 | Q9BT22 | |
| ALLLLSWVALGPRSL | 11 | P35858 | |
| LYLARGPLARLLLAW | 6 | Q75N90 | |
| GPLARLLLAWSALLC | 11 | Q75N90 | |
| LLWLLLLLLAAVAPA | 31 | Q96KC8 | |
| GLVPRLLGDILSLWL | 181 | Q9Y6C9 | |
| RLLPLLALLALWGPD | 6 | P01308 | |
| RALLLLVPAFLLIGW | 341 | Q14728 | |
| LLAVLGSGLPWLLLL | 1056 | Q5T3U5 | |
| GLRWALPLLLLLLRL | 16 | Q12913 | |
| RGELGSWRLLLLLLL | 6 | Q9Y5H6 | |
| VPEARLLGLALAWLR | 191 | Q8N239 | |
| PAQLLGLLLLWLRGA | 6 | P04432 | |
| WALLAFALPALLLLG | 176 | Q9BZJ7 | |
| ALRGLLLLCLWLPSG | 21 | Q86VZ4 | |
| PRWRSALLLLFLAGV | 11 | Q9Y561 | |
| PLLLLLLLLAWCAGA | 21 | P48645 | |
| LRLLLFVALPASGWL | 11 | Q9NU53 | |
| LLGLAIAGPVLAWRL | 176 | Q8N386 | |
| WRLLIFLGLLALPLA | 6 | Q9BQP9 | |
| LLLLVLLCLPAVWGD | 21 | P08174 | |
| LLLLPLLAGARLLWN | 6 | P08686 | |
| LLPVGLLLLAAAWCL | 191 | P49771 | |
| AWTRALLLPLLLAGP | 11 | P14543 | |
| RGSLGSRLLLLWLLL | 6 | Q9Y5H7 | |
| PLLLLLLAAPWGRAV | 16 | Q9UHF4 | |
| LARQLLLLLWLLEAP | 51 | Q9UP38 | |
| LLLLWLLEAPLLLGV | 56 | Q9UP38 | |
| WLLLLLLASLLPSAR | 36 | O75173 | |
| WLVNRLPGLKDLLLA | 971 | Q9Y2K7 | |
| ELLLLGAAWLAGPAR | 6 | P23435 | |
| APRRLSWAALLLLAA | 11 | Q4ZHG4 | |
| GDLGWRLSLLLLPLL | 6 | Q8NEV9 | |
| TLRVRWLLLLGLVGP | 11 | Q13443 | |
| GRHPSLLLLLVLLLW | 6 | Q8IXH8 | |
| QLLGLLLLWLPGARC | 6 | A0A0C4DH67 | |
| PAQLLGLLLLWLRGA | 6 | P01597 | |
| SCLPGSLLLWALLLL | 6 | O95967 | |
| AILALLPALGLLLWG | 96 | O43653 | |
| LLPGLAALVQDWRLL | 231 | A6NKX4 | |
| AGFCPLLLLLLLGLW | 6 | Q9H1E1 | |
| LLLLLLLGLWVAEIP | 11 | Q9H1E1 | |
| RNRPGAAWAVLLLLL | 6 | Q9NQ36 | |
| GALLWVLLLNLGPRA | 6 | Q9BUN1 | |
| WAPVLLLALGLRGLQ | 6 | Q9UHL4 | |
| RLLPLLALLALWGPD | 6 | F8WCM5 | |
| GLLLRALQLLLWGHL | 6 | Q9H239 | |
| YRPLWALLIAGLALV | 371 | Q9BTV4 | |
| LLLLLLATGLALAWR | 41 | Q14761 | |
| ARALAALGWLLALLL | 161 | Q8NGU9 | |
| ALGWLLALLLALPPA | 166 | Q8NGU9 | |
| LVLGLVLPLILWADR | 6 | Q9HAT2 | |
| ILLSLFLIPRAGWLA | 96 | Q96JT2 | |
| PAWLRALGALLLLAL | 221 | Q9NRU3 | |
| LLLVATLGLGRWLQP | 16 | P60852 | |
| SPLLLLFALWIRIGA | 551 | P04844 | |
| LRKWGQLLLPSLLDL | 296 | Q86U17 | |
| RLALLCALPWLLLAA | 6 | Q9NXL6 | |
| WDAGPSRRLLPLLLL | 6 | Q6UWL2 | |
| LGALRWELALCLLLA | 201 | Q9NSD5 | |
| GRLLEPLWGALELLI | 86 | Q12893 | |
| LVALLALLALALLPW | 376 | C9JH25 | |
| GLPLRLRLLLLLWAA | 26 | O75326 | |
| LLGLARLCALWAALL | 6 | Q9UBV4 | |
| PYWRLRLGGAALLLL | 11 | P53801 | |
| LLLALLLCWDPRLSQ | 11 | Q8IZJ1 | |
| VLPWALVAGLLLLLL | 26 | P41273 | |
| PRLLLWFKRGLALAA | 146 | O00337 | |
| AAAAALWLLLLLLPR | 11 | Q9HD45 | |
| LCLPLLLLLSGWSRA | 11 | Q9BZM5 | |
| RLLLLPLLLGWGLRV | 21 | Q96T83 | |
| SLWGLLAPASLLRRL | 16 | Q9NQE7 | |
| LRLFLLQGILRLLWG | 11 | Q96GX1 | |
| LLGTLLQPAVWRALL | 71 | Q5T230 | |
| RLLALWALAAVALPG | 6 | Q96S16 |